Information  X 
Enter a valid email address

Thorpe(F.W.) PLC (TFW)

  Print      Mail a friend

Friday 09 November, 2018

Thorpe(F.W.) PLC

Exercise of Options, Treasury shares and TVR

RNS Number : 9499G
Thorpe(F.W.) PLC
09 November 2018
 

FW Thorpe Plc

("FW Thorpe" or the "Company")

 

Exercise of Share Options, Transaction in Own Shares and Total Voting Rights

 

FW Thorpe announces that it was notified on 9 November 2018 that under the Executive Share Option Plan an employee exercised share options ("Share Options") over a total of 20,000 ordinary shares of 1 pence each in the Company ("Ordinary Shares").

 

To satisfy the exercise of the Share Options, 20,000 existing Ordinary Shares were transferred from treasury. 

 

Total voting rights

 

The issued share capital of the Company comprises 118,935,590 Ordinary Shares. Following the exercise of the Share Options referred to above, the Company holds 2,949,546 Ordinary Shares in treasury. Therefore, the total number of voting rights in the Company is 115,986,044.  This figure of 115,986,044 may be used by the Company's shareholders as the denominator for the calculation by which they will determine whether they are required to notify their interest in, or a change to their interest in, the share capital of FW Thorpe under the DTRs.

 

For further information, please contact:

 

F W Thorpe Plc

Mike Allcock - Chairman and Joint Chief Executive                                               Tel:  01527 583200

Craig Muncaster - Joint Chief Executive and Financial Director                             

 

N+1 Singer - Nominated Adviser                                                        

Richard Lindley/James Moat                                                                                  Tel:  020 7496 3000

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
IOEBLBITMBJMBLP

a d v e r t i s e m e n t